EACS2023: 937 The burden of CHEMSEX in Normandy, France: results of a systematic screening of drugs use in STI centers G. Unal , C. Guillois , V. Berna , N. El Forzly , F. Lamme , C. Galimard , L. Legrain , A. Lesourd , M. Etienne , COREVIH Normandie - Cegidd Coordination Study Group COREVIH Normandie, Rouen, France, COREVIH Normandie, Le Havre, France, CHU de Rouen, Service d'Addictologie, Rouen, France, Aides Normandie, Rouen, France, CeGIDD de la Miséricorde, Caen, France, CHU de Rouen, Service des Maladies Infectieuses, Rouen, France, CHU de Rouen, Service de Maladies Infectieuses, Rouen, France, Univ Rouen Normandie, Univ de Caen Normandie, INSERM, DYNAMICURE UMR 1311, CHU Rouen, Department of Infectious Disease, Rouen, France General data Abstract category: Access and delivery of care Abstract body Purpose: The practice of "chemsex", i.e the use of psychoactive substances for sexual practices, is associated with an increased risk of sexual transmitted infections (STIs) and life-altering consequences. Limited data are available on chemsex outside major cities in France. The aim of our study was to investigate the practice of chemsex among individuals consulting in STI centers in Normandy, France. Method: All STI centers in Normandy decided,over a year, to systematically question people consulting for STI test or HIV-PREP prescription on chemsex practice. Data were collected on psychoactive substance use, and impact of chemsex on their life. Results: Between May 2022 and May 2023, 119 (1,4%) people consulting in 9 STI centers in Normandy, declared using drugs in a sexual context. Overall 7 (5.9 %) were women, the median age was of 32 years (IQR27, 43) , 37 % were PREP users, 33 % had received a Mpox vaccine, and 33 % were diagnosed for at least one STi during the study period (vs 5 % for other consultants p<0.001). Fifty-six users (47.1%) declared using alcohol, cocaine, cannabis and poppers but no synthetic drugs. Among the 65 synthetic drugs' users, 38 (60%) declared using 3MMC alone or with GHB (21 %), 38% were diagnosed for at least one STI, 22 % declared that chemsex impacted their personnel or professional life, and 32 % declared needing help to deal with chemsex. All chemsex users were proposed a consultation in addictology. Conclusions: In our area, 1.4% of the consultants of STI centers practiced chemsex. Though accounting for a small proportion of consultants, systematic screening for CHEMSEX practice appeared essential to STI centers to reduce risks and harms since CHEMSEX users had a high prevalence of STIs, and one third of them already felt the need of a support in addictology. General conditions 1. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after the submission deadline and I am aware that it will be published exactly as submitted.: Yes 2. I confirm that the submission of the abstract constitutes my consent to publication (e.g. conference website, programmes, other promotions, etc.). : Yes 3. I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.: Yes 4. I agree that all data provided may be used (saved, stored, processed, transmitted and deleted) in compliance with the privacy policy to provide the services described.: Yes 1 2 3 2 4 5 1 1,6 1,7,8 1 2 3 4 5 6 7 8 54 19TH EUROPEAN AIDS CONFERENCE | WARSAW 2023
RkJQdWJsaXNoZXIy Mzc2ODc=